1-2 of 2
Knut Liestøl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL

Clinical Trials & Observations
Kathrine T. Isaksen, Maria Adele Mastroianni, Marit Rinde, Leiv Sindre Rusten, Dlawer Abdulla Barzenje, Lloyd Frode Ramslien, Marit Slaaen, Marianne Brenn Jerm, Erlend B. Smeland, Siri Rostoft, Knut Liestøl, Marianne Brodtkorb, Harald Holte
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4771–4782.
https://doi.org/10.1182/bloodadvances.2021004777
Published: 2021
Includes: Supplemental data
Journal Articles

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Clinical Trials & Observations
Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn-Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiaer, Signe Spetalen, Klaus Beiske, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1906–1915.
https://doi.org/10.1182/bloodadvances.2020001518
Published: 2020
Includes: Supplemental data